ATAI Life Sciences Archives

Psychedelics News

ATAI Life Sciences

Industry

12 Oct 2022

Atai Announces Positive Phase 1 Results for Opioid Use Disorder

atai Life Sciences Announces Positive Initial Results for Phase 1 Trial of KUR-101, an Oral Formulation of Mitragynine for OUD...

By Microdose NewsDesk

Industry

7 Oct 2022

atai Life Sciences Doses First Patient in New DMT Clinical Trial

On Wednesday, atai published a press release celebrating the first patient being dosed in their Phase 1 DMT safety trial....

By James Hallifax

Finance

6 Oct 2022

Can Psychedelic Stocks Like MindMed and atai Ever Recover?

Should investors begin ringing the funeral bells for psychedelic stocks? Can psychedelic stocks Like MindMed and atai ever recover? James Hallifax takes a deeper look....

By James Hallifax

Industry

28 Sep 2022

Atai Life Sciences Launches Phase 1 MDMA Trial

atai Life Sciences Announces Initiation of Phase 1 Trial for its MDMA Derivative, EMP-01...

By Jason Najum

Join Our Newsletter for Exclusive Updates, Stories, and More

Finance, Industry

15 Aug 2022

atai Life Sciences Secures $175 Million Loan

The new loand plus $312M existing cash on hand as of June 30, 2022, gives atai access to up to $487M to continue developing next generation mental health treatments...

By Microdose NewsDesk

Finance

2 Aug 2022

Cathie Wood’s ARK Fund Buys Over 3 Million ATAI Shares

In mid-July, we had the ARK fund at a total investment of 621,812 shares for the month....

By Microdose NewsDesk

Don’t Miss

18 Jul 2022

News You Might Have Missed: July 18th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Finance, Industry

13 Jul 2022

Updated: Cathie Wood’s ARK Fund Buys More Atai Stock

Yesterday we received news of additional investment into Atai, with a purchase of 103,977 shares by Cathie Wood's ARK fund....

By Microdose NewsDesk

Don’t Miss

11 Jul 2022

News You Might Have Missed: July 11th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result